FMO5 and early-onset autosomal dominant Alzheimer disease: It also governs the equilibrium between oxidative stress and inflammatory responses by modulating the expression of antioxidant enzymes and NADPH oxidase, thus playing a pivotal role in Alzheimer’s disease progression (Islam, 2017).